Kardigan Acquires Prolaio

March 27, 2025

Kardigan has acquired Prolaio, a Chicago-based clinical intelligence company, to integrate Prolaio's cardiovascular data, FDA-cleared monitoring software, and analytics into Kardigan's cardiac R&D platform. The acquisition gives Kardigan access to a large curated CV dataset and analytics capabilities intended to accelerate and optimize its cardiovascular drug development programs.

Buyers
Kardigan
Targets
Prolaio
Industry
Data & Analytics
Location
Illinois, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.